| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Maadh Aldouri | |
| P921 | main subject | patient | Q181600 |
| P304 | page(s) | 41-46 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | Pathophysiology of Haemostasis and Thrombosis: international journal on haemostasis and thrombosis research | Q15758753 |
| P1476 | title | The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophiliac patients | |
| P478 | volume | 32 Suppl 1 |
| Q35564946 | A brief historical review of the waterfall/cascade of blood coagulation |
| Q37095548 | A review of transfusion risks and optimal management of perioperative bleeding with cardiac surgery |
| Q24797362 | An in vitro evaluation of standard rotational thromboelastography in monitoring of effects of recombinant factor VIIa on coagulopathy induced by hydroxy ethyl starch |
| Q35916437 | An overview of blood-sparing techniques used in spine surgery during the perioperative period |
| Q36262718 | Coagulopathy in traumatic brain injury |
| Q33369021 | Control of bleeding caused by thrombocytopenia associated with hematologic malignancy: an audit of the clinical use of recombinant activated factor VII. |
| Q53252658 | Critical bleeding in vascular surgery: expanding the indication of recombinant activated factor VII. |
| Q45870509 | Dosing factor VIIa (recombinant) in nonhemophiliac patients with bleeding after cardiac surgery |
| Q37691716 | Hemostatic and neuroprotective effects of human recombinant activated factor VII therapy after traumatic brain injury in pigs |
| Q38168784 | Hemostatic strategies for traumatic and surgical bleeding |
| Q36263592 | Intraoperative pediatric blood transfusion therapy: a review of common issues. Part II: transfusion therapy, special considerations, and reduction of allogenic blood transfusions |
| Q42139651 | Poly-N-acetylglucosamine fibers amplify the effectiveness of recombinant factor VIIA on clot formation in hemophilia B canine blood |
| Q35839531 | Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding |
| Q33365354 | Recombinant activated factor VII in patients at high risk of bleeding |
| Q45861831 | Recombinant activated factor VII. |
| Q36372563 | Recombinant coagulation factor VIIa--a novel haemostatic agent in scoliosis surgery? |
| Q33363658 | Recombinant factor VIIa |
| Q35617174 | Recombinant factor VIIa (rFVIIa) and its use in severe bleeding in surgery and trauma: a review |
| Q36263655 | Recombinant factor VIIa as an adjunctive therapy for patients requiring large volume transfusion: a pharmacoeconomic evaluation |
| Q36077574 | Recombinant factor VIIa in the treatment of non-hemophiliac bleeding |
| Q45872694 | Successful use of recombinant factor VIIa for severe surgical liver bleeding in a 5 month-old baby |
| Q41957484 | The interaction of factor VIIa with rehydrated, lyophilized platelets |
| Q45882489 | The use of recombinant factor VIIa for bleeding in paediatric practice |
| Q48189648 | Use of Activated Recombinant Factor VII (NovoSeven) During Neurosurgery |
| Q50664916 | Use of recombinant activated factor VII to arrest uncontrolled bleeding: a case series. |
| Q36375859 | Use of recombinant factor VIIa (NovoSeven) in pediatric cardiac surgery. |
Search more.